Medical Therapy of Glaucoma: New Targets and Drug Combinations

Target Audience

This activity is intended to meet the needs of ophthalmologists and glaucoma specialists.
Learning Objectives

Upon completion of this activity, participants should be better able to:

Review the risk factors for glaucoma and the impact of increased intraocular pressure (IOP) on patient outcomes
Discuss the current use of existing and novel pharmacotherapies for patients with open angle glaucoma
Evaluate the clinical trials results of newly approved ocular hypotensive agents, including ROCK inhibitors and combination agents
Discuss the mechanisms of action of the new and emerging medications and the novel medication targets within the trabecular meshwork ^TM
Evaluate the clinical trials results of newly approved ocular hypotensive agents, including ROCK inhibitors and combination agents
Review strategies for setting patient expectations and improving patient compliance with glaucoma therapy